MESSINA, SILVIA
 Distribuzione geografica
Continente #
EU - Europa 54
AS - Asia 38
NA - Nord America 20
SA - Sud America 3
OC - Oceania 2
Totale 117
Nazione #
IT - Italia 22
US - Stati Uniti d'America 19
SG - Singapore 17
CN - Cina 12
CH - Svizzera 9
SE - Svezia 5
FI - Finlandia 4
RU - Federazione Russa 4
DE - Germania 3
IN - India 3
JP - Giappone 3
AU - Australia 2
BR - Brasile 2
MY - Malesia 2
NL - Olanda 2
PL - Polonia 2
RS - Serbia 2
CA - Canada 1
HU - Ungheria 1
IL - Israele 1
UY - Uruguay 1
Totale 117
Città #
Singapore 15
Caldwell 4
Milan 4
Lappeenranta 3
Shanghai 3
Belgrade 2
Castellina in Chianti 2
Kuala Lumpur 2
Machida 2
New York 2
Parma 2
Porto Alegre 2
Amsterdam 1
Arakawa 1
Basel 1
Boardman 1
Budapest 1
Chennai 1
Decatur 1
Florence 1
Helsinki 1
Jerusalem 1
Lawrence 1
Mancherial 1
Melbourne 1
Montecatini Terme 1
Montevideo 1
Moscow 1
Naples 1
Nuremberg 1
Princeton 1
Sennori 1
St Louis 1
Taizhou 1
Vimodrone 1
Warsaw 1
Wroclaw 1
Wuhan 1
Wuxi 1
Xi'an 1
Totale 71
Nome #
Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios 64
The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis 17
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 16
null 12
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study (Neurology and Therapy, (2024), 13, 3, (611-624), 10.1007/s40120-024-00591-z) 11
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 11
The influence of MOGAD on diagnosis of multiple sclerosis using MRI 5
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 5
Totale 141
Categoria #
all - tutte 915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 0 0 0 0 0 0 0 16 5
2022/202330 7 4 1 4 3 4 1 3 0 0 0 3
2023/202434 0 3 1 3 2 3 9 3 5 1 2 2
2024/202556 9 6 11 15 15 0 0 0 0 0 0 0
Totale 141